Clinical Trial: Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary

Brief Summary: It's a phase 2, single arm study of gemcitabine an docetaxel combination in patients with carcinoma of unknown primary.